NRx Pharmaceuticals

NRx Pharmaceuticals Completes Enrollment in Pivotal Trial for Suicidal Bipolar Depression Treatment

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a Pennsylvania-based biopharmaceutical company, recently announced it has completed enrollment for its Phase 2b/3 study of NRX-101. This patented combination of D-cycloserine, …

NRx Pharmaceuticals Completes Enrollment in Pivotal Trial for Suicidal Bipolar Depression Treatment Read More